Vangelis Vergetis has been working in the intersection of healthcare, technology, and data science for more than 15 years. He is currently the co-founder and CEO of Epikast, a company that partners with biopharmaceutical companies as they rethink how to engage the stakeholders that matter the most: patients, caregivers, and physicians. He spent about a dozen years as a consultant at McKinsey and at Hakluyt, working with biopharmaceutical companies on several topics – particularly in launching drugs across disease areas, and in designing and putting in place their commercial models and infrastructure. Immediately prior to Epikast, Vangelis was the co-founder and CEO of Intelligencia, a software company that utilizes AI to assess and reduce the risk of clinical trials. He currently serves as a board advisor to Intelligencia. Vangelis is a board member and member of the executive committee at the Alliance for AI in Healthcare (AAIH), and a former member of the advisory board for Cornell’s Bowers College of Computer & Information Science (CIS). He holds a PhD in Electrical Engineering from the University of Pennsylvania, and a BS in Computer Science from Cornell.